Early Outcomes of Two Treatment Modes of PresbyLASIK: Monocular vs. Micro-Monovision
Publication Name
Clinical Ophthalmology
Abstract
Purpose: To report the visual, refractive and subjective outcomes of presbyLASIK for the correction of presbyopia. Methods: Monocular (20 eyes) or micro-monovision (12 eyes) presbyLASIK was performed on a total of 32 eyes in 16 patients (50% female, average age 55±4.6 years) using the Zeiss VisuMax 400Hz femtosecond and Schwind Amaris 1050RS excimer laser platform. Predictability, safety and efficacy were assessed and compared at 4–6 weeks, 3 months and 6 months. Results were considered significant if P < 0.05. Results: For monocular treatments, average postoperative spherical equivalent (SE) was 0.1±0.1 D and −0.86±0.5 D at 4–6 weeks postoperatively for distance and near eyes respectively; 90% eyes achieved SE ±1.0 D of the target. Postoperative binocular uncorrected distance (UDVA), intermediate (UIVA) and near visual acuity (UNVA) were −0.03±0.1 LogMAR (20/20), 0.09±0.26 LogMAR (N4) and 0.29±0.11 LogMAR (N6) respectively with 90% patients achieving binocular UDVA of 20/20 or better. For micro-monovision treatments, average postoperative SE was −0.33±0.51 D and −1.60±0.78 D at 4–6 weeks postoperatively for distance and near eyes respectively; 100% eyes achieved SE ±1.0 D of the target. Postoperative binocular UDVA, UIVA and UNVA were 0.05±0.16 LogMAR (20/20), −0.02±0.10 LogMAR (N3) and 0.23±0.08 LogMAR (N5) respectively with 67% patients achieving binocular UDVA of 20/20 or better. Conclusion: Monocular and micro-monovision presbyLASIK are both effective options for the treatment of presbyopia. Monocular treatments are more likely to be well tolerated by patients who prefer to preserve exceptional distance vision, while micro-monovision treatments may be better suited to patients who can tolerate compromises in distance vision in order to attain greater intermediate vision function.
Open Access Status
This publication may be available as open access
Volume
16
First Page
3597
Last Page
3606